MAPT and Alzheimer disease: During the pathogenesis of AD, the tau protein undergoes post-translational modifications, such as hyperphosphorylation (p-tau) and citrullination (Cit-tau), which have an increased tendency to create toxic oligomers (Oligo-tau) [46, 68].